PRR12
protein-codingproline rich 12
Gene summary
This gene encodes a proline-rich protein that contains two A-T hook DNA binding domains. A chromosomal translocation and gene fusion between this gene and zinc finger, MIZ-type containing 1 (Gene ID: 57178) may underlie intellectual disability and neuropsychiatric problems in a human patient. Enriched expression of this gene in embryonic mouse brain suggests that this gene may play a role in nervous system development. [provided by RefSeq, Jul 2016]
- KIAA1205
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~35.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0971007
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0859193
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0971007
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0859193
Submitter: ClinGen
The PRR12 gene is located on chromosome 19 at 19q13.33 and encodes the protein proline rich 12. PRR12 was first reported in relation to autosomal dominant neuroocular syndrome in 2018 (Leduc et al., PMID: 29556724). This gene-disease relationship is supported by strong case-level evidencea but no experimental evidence has been scored. Seven variants (2 frameshift, 2 nonsense, 2 essential splice sites (one inherited from an affected parent), and 1 missense) that have beene reported in seven probands from three publications are included in this curation (PMIDs: 29556724, 33824499, 33314030). More evidence is available in the literature (over 28 additional cases, mostly protein truncating variants but occasional missense without functional evidence have been reported), but the maximum score for genetic evidence (12 pts.) has been reached. Haploinsufficiency/loss of function is the suggested mechanism of disease. The function of the PRR12 protein has not been well characterized, and little supporting experimental evidence is available. PRR12 has been suggested to physically interact with SOX2 (PMID: 28794006), which is associated with a clinical phenotype with overlapping features, syndromic microphthalmia. Predicted reduced PRR12 expression has also been associated with acquired ocular and renal clinical phenotypes in human biobank data (PMID: 33824499). However, the SD-GCEP did not think these data were strong enough to score within the framework for this monogenic gene-disease relationship. In summary, PRR12 is definitively associated with autosomal dominant neuroocular syndrome. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date 01/19/2024 (SOP Version 10).
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic; Renal
Intervention: Cardiovascular; Renal
Rationale: The condition can include congenital anomalies such as cardiac and renal anomalies, and awareness may allow early interventions (eg, surgical repair of cardiac anomalies)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PRR12 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_020719.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 139 | 21 | 167 | ||
| missense | 3 | 447 | 110 | 2 | 562 | |
| nonsense | 12 | 9 | 5 | 26 | ||
| start loss | 0 | |||||
| frameshift | 35 | 27 | 1 | 63 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 1 | 3 | ||
| Total | 48 | 40 | 461 | 249 | 23 | 821 |
Highest pathogenic variant AF is 0.000009787021
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_065770.1 | 14 | MANE Select | |
| Ensembl | ENSP00000394510.1 | 14 | MANE Select | |
| Ensembl | ENSP00000812664.1 | 14 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Cellular Component
- nucleus
- postsynaptic density
- cell junction
- neuron projection
- postsynaptic membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000418929
- Coding exons
- 14
- Length
- 34797
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.98 | 970 | 1.27e+3 | 0.765 | 0.0000859 | 12597 |
| Missense (PolyPhen) | 120 | 201.01 | 0.597 | 1845 | ||
| Synonymous | -3.29 | 689 | 588 | 1.17 | 0.0000443 | 4644 |
| Loss of Function | 7.04 | 0 | 57.7 | 0.00 | 0.00000284 | 700 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.114
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.186
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |